Pendal Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BG
Pendal Group's BSX Position: Q4 2022 in Review
Pendal Group reduced its Boston Scientific (BSX) stake by 2% in Q4 2022, selling an estimated $9.4K and leaving 10,612 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #375.
Pendal Group first reported a position in BSX in Q4 2018 and has held it in 17 quarters since. The position peaked at $2.59M in Q4 2021. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.
- Pendal Group held 10,612 shares of Boston Scientific worth $491K as of Q4 2022.
- Pendal Group sold 217 Boston Scientific shares in Q4 2022, an estimated $9.4K.
- Boston Scientific made up ﹤0.01% of Pendal Group's portfolio in Q4 2022, its #375 holding.
- Pendal Group first reported a position in Boston Scientific in Q4 2018 and has held it in 17 quarters since.
- Pendal Group's Boston Scientific position peaked at $2.59M in Q4 2021.
- 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.
Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.